Code | 5225E | ||||||||||
MA number | 18/0001/24-S | ||||||||||
Product Form: | tbl flm 196 (2x98)x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al - viacn.bal.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Vipharm S.A., Poland | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 21 | ||||||||||
Container: | blister PVC/PE/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 20.01.2024 |
Validity: | 20.01.2029 |
PIL: | PIL_Ansifora Duo 50 mg_1000 mg_tbl flm_01_2024.pdf |
SPC: | SPC_Ansifora Duo 50 mg_1000 mg_tbl flm_01_2024.pdf |
Safety feature | Yes |
Data update: | 25.01.2024 |